Provided by Tiger Fintech (Singapore) Pte. Ltd.

Tonix Pharmaceuticals

46.91
-0.2800-0.59%
Post-market: 47.720.8100+1.73%19:59 EDT
Volume:1.49M
Turnover:69.36M
Market Cap:347.41M
PE:-0.27
High:48.80
Open:48.74
Low:45.50
Close:47.19
Loading ...

Tonix Pharmaceuticals Announces Presentation of New Data on Mpox and Smallpox Vaccine Candidate Tnx-801 at the Vaccine Congress 2025

THOMSON REUTERS
·
10 Jul

Tonix Pharmaceuticals Announces Presentation of New Data on Mpox and Smallpox Vaccine Candidate TNX-801 at the Vaccine Congress 2025

GlobeNewswire
·
10 Jul

Tonix Pharmaceuticals Announces on-Line Publication of Phase 3 Resilient Trial Results of Tnx-102 Sl for Fibromyalgia in the Peer Reviewed Journal, Pain Medicine

THOMSON REUTERS
·
10 Jul

Tonix Pharmaceuticals Announces On-line Publication of Phase 3 RESILIENT Trial Results of TNX-102 SL for Fibromyalgia in the Peer Reviewed Journal, Pain Medicine

GlobeNewswire
·
10 Jul

Tonix Pharmaceuticals Unveils New Investor Presentation Highlighting Development in Pain, Immunology, and Infectious Disease Solutions

Reuters
·
08 Jul

Tonix Pharmaceuticals to present on Mpox, smallpox vaccine candidate TNX-801

TIPRANKS
·
07 Jul

Tonix Pharmaceuticals Announces Oral Presentation on Mpox and Smallpox Vaccine Candidate Tnx-801 at the Vaccine Congress 2025

THOMSON REUTERS
·
07 Jul

Tonix Pharmaceuticals Announces Oral Presentation on Mpox and Smallpox vaccine candidate TNX-801 at the Vaccine Congress 2025

GlobeNewswire
·
07 Jul

Tonix Pharmaceuticals announces peer-reviewed publication of data on mTNX-1700

TIPRANKS
·
02 Jul

Tonix Pharmaceuticals announces inclusion in Russell 3000, Russell 2000 indexes

TIPRANKS
·
30 Jun

Tonix Pharmaceuticals Unveils Presentation on Innovative Therapies and Vaccines for CNS, Immunology, and Infectious Disease

Reuters
·
17 Jun

Tonix Pharmaceuticals presented data, analyses of TNX-102 SL treatment effects

TIPRANKS
·
16 Jun

Press Release: Tonix Pharmaceuticals Announces Appointment of Commercial Industry Veteran, James "Jim" Hunter, to Board of Directors

Dow Jones
·
13 Jun

Tonix Pharmaceuticals Unveils Presentation on Therapeutics for Pain, Neurologic, and Infectious Diseases

Reuters
·
12 Jun

Tonix Pharmaceuticals Files for Mixed Shelf of up to $500 Mln - SEC Filing

THOMSON REUTERS
·
12 Jun

Tonix Pharmaceuticals Shares Down 13.9% Premarket After Co Enters Agreement to Sell up to $150 Mln of Shares

THOMSON REUTERS
·
12 Jun

Tonix Pharmaceuticals Holding Corp - May Sell up to $150 Mln in Common Stock - SEC Filing

THOMSON REUTERS
·
12 Jun

Tonix Pharmaceuticals Enters $150 Million Sales Agreement with A.G.P. and $75 Million Purchase Agreement with Lincoln Park

Reuters
·
12 Jun

BRIEF-Tonix Pharmaceuticals Announces First Patient Dosed In Phase 2 Oasis Study Of TNX-102 SL For Reduction Of Acute Stress Reaction

Reuters
·
21 May

Tonix Pharmaceuticals Announces First Patient Dosed in Phase 2 Oasis Study of Tnx-102 Sl for Reduction of Acute Stress Reaction

THOMSON REUTERS
·
21 May